Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-012067
Filing Date
2017-11-14
Accepted
2017-11-14 15:57:04
Documents
58
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0917_chinapharma.htm 10-Q 323473
2 CERTIFICATION f10q0917ex31-1_chinapharma.htm EX-31.1 12719
3 CERTIFICATION f10q0917ex31-2_chinapharma.htm EX-31.2 11712
4 CERTIFICATION f10q0917ex32-1_chinapharma.htm EX-32.1 6843
  Complete submission text file 0001213900-17-012067.txt   2244355

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cphi-20170930.xml EX-101.INS 326240
6 XBRL SCHEMA FILE cphi-20170930.xsd EX-101.SCH 29872
7 XBRL CALCULATION FILE cphi-20170930_cal.xml EX-101.CAL 44082
8 XBRL DEFINITION FILE cphi-20170930_def.xml EX-101.DEF 35838
9 XBRL LABEL FILE cphi-20170930_lab.xml EX-101.LAB 252245
10 XBRL PRESENTATION FILE cphi-20170930_pre.xml EX-101.PRE 164412
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1230
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 171201277
SIC: 2834 Pharmaceutical Preparations